ArticleMolecular cancer therapeutics2017

A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.

Ming-Hsien Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.